CERENOME, INC. (CNSY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2M 4M 6M Q1 '16: 5.3M Q2 '16: 4.8M Q3 '16: 4.7M Q4 '16: 4.7M Q1 '17: 3.9M Q2 '17: 3.8M Q3 '17: 3.5M Q4 '17: 2.7M Q1 '18: 2.8M Q2 '18: 2.5M Q3 '18: 2.9M Q4 '18: 3.7M Q1 '19: 3.6M Q4 '24: 5.8M Q1 '25: 5.2M Q2 '25: 5.3M Q3 '25: 5.3M Q4 '25: 5.2M Q1 '26: 5.2M Q2 '26: 4.2M Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 1.5M 3M 4.5M Q4 '13: 3.7M Q1 '14: 3.7M Q2 '14: 3M Q3 '14: 2.5M Q4 '14: 2M Q1 '15: 1.7M Q2 '15: 1.9M Q3 '15: 1.9M Q4 '15: 1.7M Q1 '16: 2.1M Q2 '16: 2.3M Q3 '16: 2.2M Q4 '16: 1.9M Q1 '17: 1.1M Q2 '17: 771K Q3 '17: 638K Q4 '17: 146K Q1 '18: 423K Q2 '18: 191K Q3 '18: 441K Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17 Q3 '18

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q3 '21: -11.9M Q4 '21: -12.5M Q1 '22: -13.9M Q2 '22: -16.5M Q3 '22: -18.1M Q4 '22: -19.7M Q1 '23: -20.5M Q2 '23: -16.9M Q3 '23: -15M Q4 '23: -13.3M Q1 '24: -11.9M Q2 '24: -14.1M Q3 '24: -14.7M Q4 '24: -14.7M Q1 '25: -14.9M Q2 '25: -12.8M Q3 '25: -13.5M Q4 '25: -15.3M Q1 '26: -18.9M Q2 '26: -26.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-30M -20M -10M 0 10M 20M 30M Q3 '21: -12.8M Q4 '21: -13.4M Q1 '22: -14.8M Q2 '22: -17.3M Q3 '22: -18.8M Q4 '22: -20.3M Q1 '23: -21M Q2 '23: -17.2M Q3 '23: -15.2M Q4 '23: -13.3M Q1 '24: -11.8M Q2 '24: -13.2M Q3 '24: -12.9M Q4 '24: -13M Q1 '25: -27.1M Q2 '25: -19M Q3 '25: -20.6M Q4 '25: -22.4M Q1 '26: -11.9M Q2 '26: -26.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-24M -16M -8M 0 8M 16M 24M Q3 '21: -10.9M Q4 '21: -10.3M Q1 '22: -11.2M Q2 '22: -11.4M Q3 '22: -13.4M Q4 '22: -13M Q1 '23: -14.9M Q2 '23: -15M Q3 '23: -13.2M Q4 '23: -12.9M Q1 '24: -11.6M Q2 '24: -9.9M Q3 '24: -11.2M Q4 '24: -10.6M Q1 '25: -12.2M Q2 '25: -16.9M Q3 '25: -15.7M Q4 '25: -20.8M Q1 '26: -20.8M Q2 '26: -22.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-27M -18M -9M 0 9M 18M 27M Q3 '18: -13.9M Q4 '18: -12.1M Q1 '19: -11.2M Q2 '19: -9.6M Q3 '19: -9.4M Q4 '19: -6M Q1 '20: -4.2M Q2 '20: -4.5M Q3 '20: -4.3M Q4 '23: -13M Q1 '24: -11.7M Q2 '24: -10.1M Q3 '24: -11.4M Q4 '24: -10.7M Q1 '25: -12.3M Q2 '25: -16.9M Q3 '25: -15.8M Q4 '25: -20.8M Q1 '26: -21.7M Q2 '26: -23.5M Q4 '18 Q3 '19 Q2 '20 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '15: 9.8M Q3 '15: 10.5M Q2 '16: 14.8M Q3 '16: 20.5M Q2 '21: 11.3M Q3 '21: 13.3M Q1 '22: 21.5M Q2 '22: 1.5M Q3 '22: 1.8M Q1 '23: 2.3M Q2 '23: 2.5M Q3 '23: 3.2M Q1 '24: 4.3M Q2 '24: 10.7M Q3 '24: 7.9M Q1 '25: 582.7K Q2 '25: 8.4M Q3 '25: 107.4M Q1 '26: 6.6M Q2 '26: 6.9M Q3 '15 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q2 '20: 20.59 Q3 '20: 20.23 Q4 '20: -1.85 Q1 '21: -1.90 Q2 '21: -1.70 Q3 '21: -1.59 Q4 '21: -1.13 Q1 '22: -0.99 Q2 '22: -4.30 Q3 '22: -6.87 Q4 '22: -8.96 Q1 '23: -10.84 Q2 '23: -7.87 Q3 '23: -6.02 Q4 '23: -4.36 Q1 '24: -3.04 Q2 '24: -3.16 Q3 '24: -2.53 Q4 '24: -2.50 Q1 '25: -31.61 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.